Literature DB >> 3874231

Production of interleukin 1 activity by normal human peripheral blood B lymphocytes.

K Matsushima, A Procopio, H Abe, G Scala, J R Ortaldo, J J Oppenheim.   

Abstract

Interleukin 1 (IL 1) production by normal human B lymphocytes was investigated. Normal human peripheral blood B lymphocytes were purified by sequential separation with the use of Ficoll-Hypaque gradient centrifugation, sheep red blood cell rosette formation, Percoll gradients, and treatment with monoclonal antibodies (anti-Leu-M1, B73.1, and T101) and complement. Both purified large B lymphocytes (BL) and small B lymphocytes (BS) produced IL 1-like (thymocyte co-mitogenic and fibroblast mitogenic) activities in response to lipopolysaccharide. Maximal production of IL 1 activity by both BL and BS occurred at 48 hr. The m.w. of IL 1 activities from both BL and BS were about 20,000 with high pressure liquid chromatography, and the major isoelectric point of BL- and BS-derived IL 1 activity was 7.0. A rabbit anti-human monocyte IL 1 antiserum inhibited the activity of B cell-derived IL 1, suggesting antigenic similarities of monocyte- and B lymphocyte-derived IL 1 moieties. These data suggest that normal B lymphocyte-derived IL 1 activity is biochemically and immunologically similar to monocyte-derived IL 1.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874231

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Khoa D Nguyen; Ariana Peck; Julia Buckingham; Chetan Deshpande; Elizabeth Wong; Heather C Alexander; Sheng-Yung Chang; Ann Begovich; Yue Sun; Jane L Park; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Erin M Augustine; Carolyn Phillips; Andreas V Hadjinicolaou; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2011-12-28       Impact factor: 3.969

Review 2.  Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis.

Authors:  J Gordon; G Guy; L Walker; P Nathan; R Exley; M Clemens
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

3.  Immunological and immunohistochemical analysis of rheumatoid nodules.

Authors:  N Miyasaka; K Sato; K Yamamoto; M Goto; K Nishioka
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

4.  Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell lines.

Authors:  S S Sung; L K Jung; J A Walters; E W Jeffes; G A Granger; S M Fu
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Antibody synthesis specific for nonoral antigens in inflamed gingiva.

Authors:  S M Mallison; A K Szakal; R R Ranney; J G Tew
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

Review 6.  T cell-mediated mechanisms in autoimmune thyroiditis.

Authors:  G W Canonica; M Bagnasco; Y M Kong
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

7.  The roles of interleukins in the synergistic effect of B-cell mitogens with concanavalin A on hydrocortisone-resistant thymic cell proliferation.

Authors:  T Nitta; H Konno-Ejiri; K Nemoto; S Okumura; A Ozawa; M Nakano
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

Review 8.  B cells responses and cytokine production are regulated by their immune microenvironment.

Authors:  Monica I Vazquez; Jovani Catalan-Dibene; Albert Zlotnik
Journal:  Cytokine       Date:  2015-03-02       Impact factor: 3.861

9.  Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.

Authors:  H Wakasugi; L Rimsky; Y Mahe; A M Kamel; D Fradelizi; T Tursz; J Bertoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

10.  Expression of interleukin-1 in Reed-Sternberg cells and neoplastic cells from true histiocytic malignancies.

Authors:  S M Hsu; X Zhao
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.